Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epacadostat with CDX-1401 Vaccine in Ovarian Cancer Remission
NCT02166905Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Oct 2014
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epacadostat in ovarian carcinoma, fallopian tube carcinoma (PFTC), primary peritoneal carcinoma (PPC), sponsored by Roswell Park Comprehensive Cancer Center. Started Oct 2014; status: completed.
02
Drugs
epacadostat
03
Conditions
ovarian carcinomafallopian tube carcinoma (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT02166905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02166905.